Abstract
The effects of chronic administration of interferon (IFN; recombinant human IFN-alphaA/D) on serotonergic binding sites in rat brain were investigated. IFN was injected daily for 2 weeks at a dose of 100000 I.U./kg, (i.p.) in male Wistar rats. IFN did not alter either [3H]ketanserin binding to 5-HT2A receptors or [3H]paroxetine binding to 5-HT transporters. Scatchard analysis of [3H]8-hydroxy-dipropylaminotetraline (8-OH-DPAT) binding to 5-HT1A receptors demonstrated the presence of high- and low-affinity binding sites in both treatment and control groups. IFN significantly increased both Kd and Bmax measures of [3H]8-OH-DPAT binding at low-affinity binding sites, but not at the high-affinity sites. These results suggest that IFN affects the low-affinity 5-HT1A receptors sites and may be involved in the development of IFN-induced psychiatric disturbances.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
8-Hydroxy-2-(di-n-propylamino)tetralin / metabolism
-
Animals
-
Brain / metabolism*
-
Carrier Proteins / metabolism
-
Cell Membrane / metabolism
-
Cerebral Cortex / metabolism
-
Hippocampus / metabolism
-
Interferon Type I / administration & dosage*
-
Interferon Type I / pharmacology
-
Ketanserin / metabolism
-
Male
-
Membrane Glycoproteins / metabolism
-
Membrane Transport Proteins*
-
Nerve Tissue Proteins*
-
Paroxetine / metabolism
-
Rats
-
Rats, Wistar
-
Receptor, Serotonin, 5-HT2A
-
Receptors, Serotonin / metabolism*
-
Receptors, Serotonin, 5-HT1
-
Recombinant Proteins
-
Selective Serotonin Reuptake Inhibitors / metabolism
-
Serotonin Antagonists / metabolism
-
Serotonin Plasma Membrane Transport Proteins
-
Tritium
Substances
-
Carrier Proteins
-
Interferon Type I
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Receptor, Serotonin, 5-HT2A
-
Receptors, Serotonin
-
Receptors, Serotonin, 5-HT1
-
Recombinant Proteins
-
Serotonin Antagonists
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors
-
Slc6a4 protein, rat
-
Tritium
-
Paroxetine
-
8-Hydroxy-2-(di-n-propylamino)tetralin
-
Ketanserin